Biocon

Healthcare

13 September, 2024

Biocon-backed Bicara Therapeutics raises $315 mn in US IPO

Bicara Therapeutics raised $315 million in its initial public offering in the United States, the TPG-backed cancer therapy developer said ......

Premium

Healthcare

10 September, 2024

Exclusive: Biocon weighs fresh funding for PE-backed biosimilars unit

Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private ......

Premium

General

12 July, 2024

Grapevine: Actis may trim Profectus stake; Goldman to double down on MoEngage

Private equity firm Actis is looking to sell a stake in Profectus Capital, a non-banking finance company that it fully ......

Healthcare

02 February, 2023

Syngene rakes in $131 mn from Singapore's GIC

Singapore’s sovereign wealth fund GIC on Wednesday invested Rs 1,075.2 crore (around $131 million) in drug research company Syngene International ......

Healthcare

05 December, 2022

Biocon Biologics appoints new MD, CEO

Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......

Premium

Finance

02 December, 2022

Deals Digest: PE, VC deals value remains little changed this week

Investments by venture capital (VC) and private equity (PE) dipped 5.9% this week to $287 million from last week’s $305 ......

Healthcare

30 November, 2022

Biocon concludes Viatris' $3 bn acquisition

Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......

Healthcare

21 June, 2022

Kiran Mazumdar-Shaw co-founded biotech startup raises Series A funding

Immuneel Therapeutics Pvt Ltd, co-founded by Biocon founder Kiran Mazumdar-Shaw, has raised around $15 million (Rs 116 crore) in a ......

Healthcare

09 December, 2021

India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol

Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news ......

Healthcare

23 February, 2021

Indian pharma firms go local seeking to end reliance on China

Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house ......